SEC Form 4 · accession 0001104659-17-034325
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E Redlick
Director
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 18, 2017 | M | 1,750 | — | A | 1,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 18, 2017 | M | 1,750 | D | — | — | Common Stock | 1,750 | 0 | D |
| Stock Option (Right to Buy)F3 | $2.46 | May 19, 2017 | A | 16,000 | A | — | May 18, 2027 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
- F2On June 2, 2016, the reporting person was granted an award of 1,750 restricted stock units, which vested with respect to 100% of the shares subject to the award on May 18, 2017, one business day prior to the Issuer's 2017 annual meeting of stockholders.
- F3Subject to Reporting Person providing continued services to the Issuer and other terms and conditions under the Issuer's 2013 Stock Incentive Plan, the option will vest and become exercisable in 12 consecutive, equal installments on each consecutive monthly anniversary of the date of grant, until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Issuer's 2018 annual meeting of stockholders.
Remarks
Exhibit Index: 24.1 Power of Attorney